Literature DB >> 20213228

Presenilin 1 gene mutation (M139I) in a patient with an early-onset Alzheimer's disease: clinical characteristics and genetic identification.

Hee-Jin Kim1, Hyun Young Kim, Chang-Seok Ki, Seung Hyun Kim.   

Abstract

Mutations in the presenilin 1 (PSEN1) gene are more commonly identified as genetic causes of early-onset familial Alzheimer's disease than mutations in the amyloid precursor protein (APP) and the presenilin 2 (PSEN2) genes. More than 100 different mutations in the PSEN1 gene have been detected, and the clinical phenotypes have been described in the literature. This paper reports the case of a 38-year-old female showing early memory impairment and having a base pair mutation from guanine (G) to cytosine (C) at codon 139 of PSEN1, which leads to the substitution of a methionine with an isoleucine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213228     DOI: 10.1007/s10072-010-0233-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Detection of the presenilin 1 gene mutation (M139T) in early-onset familial Alzheimer disease in Spain.

Authors:  R Queralt; M Ezquerra; M Castellví; A Lleó; R Blesa; R Oliva
Journal:  Neurosci Lett       Date:  2001-02-23       Impact factor: 3.046

3.  Mutation analysis of presenillin 1 gene in Alzheimer's disease.

Authors:  K Boteva; M Vitek; H Mitsuda; H de Silva; P T Xu; G Small; J R Gilbert
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

4.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

5.  Genotype-phenotype analysis in early-onset Alzheimer's disease due to presenilin-1 mutations at codon 139.

Authors:  Frank Hanisch; H W Kölmel
Journal:  Eur J Med Res       Date:  2004-07-30       Impact factor: 2.175

6.  Early-onset Alzheimer's disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study.

Authors:  A J Larner; D G du Plessis
Journal:  Eur J Neurol       Date:  2003-05       Impact factor: 6.089

Review 7.  Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update.

Authors:  Andrew J Larner; Mark Doran
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 9.  The presenilins.

Authors:  Anurag Tandon; Paul Fraser
Journal:  Genome Biol       Date:  2002-10-23       Impact factor: 13.583

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more
  7 in total

1.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

Review 2.  Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-10-17       Impact factor: 4.458

3.  A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.

Authors:  Seong Soo An; Sun Ah Park; Eva Bagyinszky; Sun Oh Bae; Yoon-Jeong Kim; Ji Young Im; Kyung Won Park; Kee Hyung Park; Eun-Joo Kim; Jee Hyang Jeong; Jong Hun Kim; Hyun Jeong Han; Seong Hye Choi; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-12-15       Impact factor: 4.458

4.  APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

Review 5.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

6.  Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.

Authors:  Celeste M Karch; Damián Hernández; Jen-Chyong Wang; Jacob Marsh; Alex W Hewitt; Simon Hsu; Joanne Norton; Denise Levitch; Tamara Donahue; Wendy Sigurdson; Bernardino Ghetti; Martin Farlow; Jasmeer Chhatwal; Sarah Berman; Carlos Cruchaga; John C Morris; Randall J Bateman; Alice Pébay; Alison M Goate
Journal:  Alzheimers Res Ther       Date:  2018-07-25       Impact factor: 6.982

Review 7.  The Genetics of Alzheimer's Disease in the Chinese Population.

Authors:  Chen-Ling Gan; Tao Zhang; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.